These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats. Jefferson FA; Xiao GH; Hein DW Toxicol Sci; 2009 Jan; 107(1):293-7. PubMed ID: 18842621 [TBL] [Abstract][Full Text] [Related]
44. The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions. Evans DA; Harmer D; Downham DY; Whibley EJ; Idle JR; Ritchie J; Smith RL J Med Genet; 1983 Oct; 20(5):321-9. PubMed ID: 6644761 [TBL] [Abstract][Full Text] [Related]
45. N-acetylation phenotyping with sulfamethazine in an Iranian population. Sardaş S; Lahijany B; Cok I; Karakaya AE Pharmacogenetics; 1993 Jun; 3(3):131-4. PubMed ID: 8334437 [TBL] [Abstract][Full Text] [Related]
46. 2-Hydroxylation of ethinyloestradiol in relation to the oxidation of sparteine and antipyrine. Back DJ; Maggs JL; Purba HS; Newby S; Park BK Br J Clin Pharmacol; 1984 Oct; 18(4):603-7. PubMed ID: 6487500 [TBL] [Abstract][Full Text] [Related]
49. Polymorphic N-acetylation of a caffeine metabolite. Grant DM; Tang BK; Kalow W Clin Pharmacol Ther; 1983 Mar; 33(3):355-9. PubMed ID: 6825389 [TBL] [Abstract][Full Text] [Related]
50. A simplified micromethod for the determination of the acetylator phenotype. Hoo JJ; Hussein L; Goedde HW J Clin Chem Clin Biochem; 1977 Jun; 15(6):329-31. PubMed ID: 894203 [TBL] [Abstract][Full Text] [Related]
51. Polymorphic acetylation of nitrazepam. Karim AK; Evans DA J Med Genet; 1976 Feb; 13(1):17-9. PubMed ID: 775091 [TBL] [Abstract][Full Text] [Related]
52. An enzyme marker to ensure reliable determinations of human isoniazid acetylator phenotype in vitro. Hein DW; Hirata M; Weber WW Pharmacology; 1981; 23(4):203-10. PubMed ID: 6976581 [TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics, metabolism, and renal excretion of sulfadimidine and its N4-acetyl and hydroxy metabolites in humans. Vree TB; Hekster YA; Nouws JF; Baakman M Ther Drug Monit; 1986; 8(4):434-9. PubMed ID: 3824429 [TBL] [Abstract][Full Text] [Related]
54. Pharmacogenetic polymorphism of drug metabolism. Paxton JW N Z Med J; 1984 Aug; 97(762):567-9. PubMed ID: 6591031 [No Abstract] [Full Text] [Related]
55. [Genetic polymorphism in sparteine oxidation--occurrence in healthy volunteers in Slovakia]. Holomán J; Glasa J; Veningerová M; Prachar V; Lukácsová M Bratisl Lek Listy; 1997 Feb; 98(2):86-90. PubMed ID: 9264814 [TBL] [Abstract][Full Text] [Related]
56. Inter-ethnic difference in sparteine oxidation among Ghanaians and Germans. Eichelbaum M; Woolhouse NM Eur J Clin Pharmacol; 1985; 28(1):79-83. PubMed ID: 3987789 [TBL] [Abstract][Full Text] [Related]
57. Acetylation and hydroxylation of sulphadimidine in the snail Cepaea hortensis. Vree TB; Vree ML; Nouws JF Zentralbl Veterinarmed A; 1986 Oct; 33(8):633-6. PubMed ID: 3101332 [No Abstract] [Full Text] [Related]
58. [Assessment of biotransformation capacity following oral administration of various model substances as cocktail]. Henschel L; Hoffmann A Z Gastroenterol; 1991 Dec; 29(12):645-9. PubMed ID: 1771946 [TBL] [Abstract][Full Text] [Related]
59. [Distribution of acetylator phenotypes in the normal Moscow city population and in chronic alcoholism]. Lil'in ET; Korsunskaia MP; Meksin VA; Drozdov ES; Nazarov VV Genetika; 1984 Sep; 20(9):1557-9. PubMed ID: 6542045 [TBL] [Abstract][Full Text] [Related]